Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Exacerbation of psoriasis in a chronic myelogenous leukemia patient treated with imatinib.

× No keyword cloud information.

7 in total

Review 1. Tyrosine kinases in inflammatory dermatologic disease.

Authors: Ricardo T Paniagua; David F Fiorentino; Lorinda Chung; William H Robinson
Journal: J Am Acad Dermatol Date: 2010-06-26 Impact factor: 11.527

2. Pityriasis rosea-like Drug Eruption Induced by Imatinib Mesylate (Gleevec™).

Authors: Ah Young Cho; Dae Hun Kim; Myung Im; Young Lee; Young Joon Seo; Jeung Hoon Lee
Journal: Ann Dermatol Date: 2011-12-27 Impact factor: 1.444

3. Pharmacological control of receptor of advanced glycation end-products and its biological effects in psoriasis.

Authors: A V Mezentsev; S A Bruskin; A G Soboleva; V V Sobolev; E S Piruzian
Journal: Int J Biomed Sci Date: 2013-09

4. Exacerbation of Psoriasis after Imatinib Mesylate Treatment.

Authors: Joon Ho Shim; Seung Hwan Oh; Ji-Young Jun; Jun-Hwan Kim; Hae-Young Park; Ji-Hye Park; Dong-Youn Lee
Journal: Ann Dermatol Date: 2016-05-25 Impact factor: 1.444

Review 5. Cutaneous complications of molecular targeted therapy used in oncology.

Authors: I Lupu; N Voiculescu; N Bacalbasa; I Cojocaru; V Vrancian; C Giurcaneanu
Journal: J Med Life Date: 2016 Jan-Mar

6. Novel factors in the pathogenesis of psoriasis and potential drug candidates are found with systems biology approach.

Authors: Máté Manczinger; Lajos Kemény
Journal: PLoS One Date: 2013-11-26 Impact factor: 3.240

7. Imatinib-induced IgA Pemphigus: Subcorneal Pustular Dermatosis Type.

Authors: Aradhana Sood; Preema Sinha; Deep K Raman; Anwita Sinha
Journal: Indian Dermatol Online J Date: 2018 Sep-Oct

7 in total